{"id":1239,"date":"2020-08-20T18:48:02","date_gmt":"2020-08-20T15:48:02","guid":{"rendered":"https:\/\/xavron.com.ua\/?post_type=publications&p=1239"},"modified":"2023-04-11T17:00:14","modified_gmt":"2023-04-11T14:00:14","slug":"yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi","status":"publish","type":"publications","link":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/","title":{"rendered":"Japanese Guidelines for the Management of Stroke 2015 [2017]."},"content":{"rendered":"

Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B).<\/p>\n","protected":false},"featured_media":656,"parent":0,"menu_order":0,"template":"","publ-cat":[33],"publ-tags":[240,53,256,245],"class_list":["post-1239","publications","type-publications","status-publish","has-post-thumbnail","hentry","publ-cat-when-stroke-en","publ-tags-acute-ischemic-stroke","publ-tags-edaravone","publ-tags-japanese-guideline-for-the-management-of-stroke","publ-tags-xavron"],"acf":[],"yoast_head":"\nJapanese Guidelines for the Management of Stroke 2015 [2017]. - Xavron<\/title>\n<meta name=\"description\" content=\"Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Japanese Guidelines for the Management of Stroke 2015 [2017]. - Xavron\" \/>\n<meta property=\"og:description\" content=\"Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/\" \/>\n<meta property=\"og:site_name\" content=\"Xavron\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-11T14:00:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/snymok-19.png\" \/>\n\t<meta property=\"og:image:width\" content=\"763\" \/>\n\t<meta property=\"og:image:height\" content=\"863\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/\",\"name\":\"Japanese Guidelines for the Management of Stroke 2015 [2017]. - Xavron\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/snymok-19.png\",\"datePublished\":\"2020-08-20T15:48:02+00:00\",\"dateModified\":\"2023-04-11T14:00:14+00:00\",\"description\":\"Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/snymok-19.png\",\"contentUrl\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/snymok-19.png\",\"width\":763,\"height\":863},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Xavron\",\"item\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publications\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"When Stroke\",\"item\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/publ-cat\\\/when-stroke-en\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Japanese Guidelines for the Management of Stroke 2015 [2017].\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/\",\"name\":\"Xavron\",\"description\":\"\u0411\u043b\u043e\u043a\u0430\u0442\u043e\u0440 \u0406\u0448\u0435\u043c\u0456\u0447\u043d\u043e\u0433\u043e \u041a\u0430\u0441\u043a\u0430\u0434\u0443\",\"publisher\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#organization\",\"name\":\"Xavron\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/xavron.png\",\"contentUrl\":\"https:\\\/\\\/xavron.com.ua\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/xavron.png\",\"width\":389,\"height\":58,\"caption\":\"Xavron\"},\"image\":{\"@id\":\"https:\\\/\\\/xavron.com.ua\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Japanese Guidelines for the Management of Stroke 2015 [2017]. - Xavron","description":"Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/","og_locale":"en_US","og_type":"article","og_title":"Japanese Guidelines for the Management of Stroke 2015 [2017]. - Xavron","og_description":"Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B)","og_url":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/","og_site_name":"Xavron","article_modified_time":"2023-04-11T14:00:14+00:00","og_image":[{"width":763,"height":863,"url":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/snymok-19.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/","url":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/","name":"Japanese Guidelines for the Management of Stroke 2015 [2017]. - Xavron","isPartOf":{"@id":"https:\/\/xavron.com.ua\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/#primaryimage"},"image":{"@id":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/#primaryimage"},"thumbnailUrl":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/snymok-19.png","datePublished":"2020-08-20T15:48:02+00:00","dateModified":"2023-04-11T14:00:14+00:00","description":"Edaravone, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B)","breadcrumb":{"@id":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/#primaryimage","url":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/snymok-19.png","contentUrl":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/snymok-19.png","width":763,"height":863},{"@type":"BreadcrumbList","@id":"https:\/\/xavron.com.ua\/en\/publications\/yaponski-rekomendacziyi-z-menedzhmentu-insultu-2015-roku-dopovneni-u-2017-roczi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Xavron","item":"https:\/\/xavron.com.ua\/en\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/xavron.com.ua\/en\/publications\/"},{"@type":"ListItem","position":3,"name":"When Stroke","item":"https:\/\/xavron.com.ua\/en\/publ-cat\/when-stroke-en\/"},{"@type":"ListItem","position":4,"name":"Japanese Guidelines for the Management of Stroke 2015 [2017]."}]},{"@type":"WebSite","@id":"https:\/\/xavron.com.ua\/en\/#website","url":"https:\/\/xavron.com.ua\/en\/","name":"Xavron","description":"\u0411\u043b\u043e\u043a\u0430\u0442\u043e\u0440 \u0406\u0448\u0435\u043c\u0456\u0447\u043d\u043e\u0433\u043e \u041a\u0430\u0441\u043a\u0430\u0434\u0443","publisher":{"@id":"https:\/\/xavron.com.ua\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xavron.com.ua\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xavron.com.ua\/en\/#organization","name":"Xavron","url":"https:\/\/xavron.com.ua\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xavron.com.ua\/en\/#\/schema\/logo\/image\/","url":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/xavron.png","contentUrl":"https:\/\/xavron.com.ua\/wp-content\/uploads\/2023\/04\/xavron.png","width":389,"height":58,"caption":"Xavron"},"image":{"@id":"https:\/\/xavron.com.ua\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publications\/1239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/types\/publications"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/media\/656"}],"wp:attachment":[{"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/media?parent=1239"}],"wp:term":[{"taxonomy":"publ-cat","embeddable":true,"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publ-cat?post=1239"},{"taxonomy":"publ-tags","embeddable":true,"href":"https:\/\/xavron.com.ua\/en\/wp-json\/wp\/v2\/publ-tags?post=1239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}